 Connection
Michael Bishop to Protein Kinase Inhibitors
This is a "connection" page, showing publications Michael Bishop has written about Protein Kinase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.864 |
|
|
|
-
Gartrell J, Mulrooney DA, Hsu CW, Pan H, Federico SM, Pappo AS, Helmig S, Meredith CJ, Pease P, Christensen AM, Beasley G, Bishop MW. Acute cardiotoxicity in pediatric and adolescent patients with solid tumors treated with tyrosine kinase inhibitors. Cancer. 2025 Jul 01; 131(13):e35940.
Score: 0.825
-
Whittle SB, Offer K, Roberts RD, LeBlanc A, London C, Majzner RG, Huang AY, Houghton P, Alejandro Sweet Cordero E, Grohar PJ, Isakoff M, Bishop MW, Stewart E, Slotkin EK, Greengard E, Borinstein SC, Navid F, Gorlick R, Janeway KA, Reed DR, Hingorani P. Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force. Pediatr Blood Cancer. 2021 09; 68(9):e29188.
Score: 0.039
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|